FDA Adverse Event Injury Summary report: N

VERSAWRAP

MDR report key: 17845456 · Received September 29, 2023

Report

Report Number
3012669262-2023-00003
Event Type
Injury
Date Received
September 29, 2023
Date of Event
August 7, 2023
Report Date
September 13, 2023
Manufacturer
ALAFAIR BIOSCIENCES
Product Code
FTM
UDI-DI
B454VTP22010
PMA / PMN Number
K213163
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION INTO THIS FEEDBACK INCLUDED 1) A REVIEW OF THE FEEDBACK DETAILS, 2) A REVIEW OF THE DEVICE LOT HISTORY RECORD, 3) A REVIEW OF THE COMPLAINT DATABASE, 4) COMMUNICATION WITH THE SURGEON AND DISTRIBUTOR, AND 5) A REVIEW OF THE IFU. NO ANOMALIES WERE FOUND, THE ROOT CAUSE OF THE INFECTION IS UNLIKELY RELATED TO VERSAWRAP.

Description of Event or Problem · 0

ON (B)(6) 2023, USING A DA VINCI SYSTEM, A PERITONECTOMY WAS PERFORMED. VERSAWRAP WAS APPLIED TO THE RAW SURFACES WHERE THE PERITONEUM WAS REMOVED. AMNIOFIX (MIMEDX) WAS ALSO USED IN THE PROCEDURE. TWO (2) WEEKS POSTOPERATIVE THE PATIENT PRESENTED WITH FEVER AND PAIN. MRI IDENTIFIED FLUID NEAR THE FALLOPIAN TUBE. THE PATIENT WAS TREATED WITH ORAL ANTIBIOTICS. A REVIEW OF THE DEVICE LOT HISTORY RECORDS INDICATED THE DEVICE WAS MANUFACTURED TO SPECIFICATIONS. THE DEVICE IS PROVIDED TO THE END USER AS A STERILE DEVICE. THE DEVICE WOULD NOT CAUSE AN INFECTION. ALAFAIR BIOSCIENCES HAS A VALIDATED STERILIZATION CYCLE WITH A STERILITY ASSURANCE LEVEL OF (SAL) 10^-6. THE VALIDATED STERILITY CYCLE AND ALL PARAMETERS OF ALL DEVICES ARE VERIFIED PRIOR TO RELEASE FOR DISTRIBUTION. THE ROOT CAUSE OF THE PRESENCE OF A PELVIC ABSCESS IS INCONCLUSIVE. IN A SUBSEQUENT CONVERSATIONS WITH THE SURGEON, THE SURGEON INDICATED THAT THE PATIENT RECOVERED AND IS DOING WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
343375 VERSAWRAP TENDON / NERVE PROTECTOR FTM ALAFAIR BIOSCIENCES VTP-2201 001309641-1001 B454VTP22010

Patients

Seq Age Sex Outcome Treatment
1 42 YR Female Required Intervention AMNIOFIX